Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The application process takes two to four weeks
PMCID: PMC5423673
107 In prostate cancer, anti-androgen therapies such as enzalutamide induce the histone reader ZMYND8, which cooperates with FOXM1 to activate neuroendocrine transcriptional programs (e.g., ASCL1), facilitating transdifferentiation into neuroendocrine prostate cancer (NEPC)
I remember reading that statins have plaque stabilizing effects
This review summarizes updated research findings regarding the adverse effects of GLP-1 RAs, their mechanisms of action, and guidelines for clinical application
10.1248/bpb.b23-00477 94 MannaK.KhanZ
/assets/images/provider/photos/2798511.png)
US$ 28.74
US$ 29.76
US$ 22.37
US$ 22.42
US$ 24.76
US$ 20.10
